Samuel R Meier
6PUBLICATIONS
101CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 29, 2025
TNG260 Is a Small-Molecule CoREST Inhibitor That Sensitizes STK11-Mutant Tumors to Anti-PD-1 Immunotherapy.Leanne G Ahronian, Soumyadip Sahu, Minjie Zhang
|May 06, 2025
CRISPR Screens Identify POLB as a Synthetic Lethal Enhancer of PARP Inhibition Exclusively in BRCA-Mutated Tumors.Katherine Lazarides, Justin L Engel, Michele Meseonznik
|Jan 31, 2025
Characterization of TNG348: A Selective, Allosteric USP1 Inhibitor That Synergizes with PARP Inhibitors in Tumors with Homologous Recombination Deficiency.Antoine Simoneau, Charlotte B Pratt, Hsin-Jung Wu
|Oct 13, 2022
Ubiquitinated PCNA Drives USP1 Synthetic Lethality in Cancer.Antoine Simoneau, Justin L Engel, Madhavi Bandi
|Sep 07, 2022
VRK1 Is a Synthetic-Lethal Target in VRK2-Deficient Glioblastoma.Julie A Shields, Samuel R Meier, Madhavi Bandi
Pageof 1
Frequent Collaborators
6 joint publications
Jannik N Andersen
5 joint publications
Douglas A Whittington
5 joint publications
Alan Huang
5 joint publications
Yi Yu
5 joint publications
Binzhang Shen
4 joint publications
Madhavi Bandi
4 joint publications
John P Maxwell
4 joint publications
Minjie Zhang
3 joint publications
Yingnan Chen
3 joint publications
Justin L Engel
